Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Fischer S, Gillessen S, Stalder O, Terbuch A, Cathomas R, Schmid FA, Zihler D, Müller B, Fankhauser CD, Hirschi-Blickenstorfer A, Kluth LA, Seifert B, Templeton AJ, Mingrone W, Ufe MP, Fischer N, Beyer J, Woelky R, Omlin A, Vogl U, Hoppe K, Kamradt J, Rothschild SI, Rothermundt C. Fischer S, et al. Among authors: vogl u. Eur Urol Open Sci. 2024 Sep 11;68:68-74. doi: 10.1016/j.euros.2024.08.008. eCollection 2024 Oct. Eur Urol Open Sci. 2024. PMID: 39308640 Free PMC article.
Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic review.
Kaufmann E, Aeppli S, Arnold W, Balermpas P, Beyer J, Bieri U, Cathomas R, de Bari B, Dressler M, Engeler DS, Erdmann A, Gallina A, Gomez S, Guckenberger M, Herrmann TRW, Hermanns T, Ilaria L, John H, Kessler TM, Klein J, Laouiti M, Lauffer D, Mattei A, Müntener M, Nguyen D, Niederberger P, Papachristofilou A, Prause L, Reinhardt K, Salati E, Sèbe P, Shelan M, Strebel R, Templeton AJ, Vogl U, Wettstein MS, Zihler D, Zilli T, Zwahlen D, Roth B, Fankhauser C. Kaufmann E, et al. Among authors: vogl u. World J Urol. 2024 Sep 19;42(1):527. doi: 10.1007/s00345-024-05196-7. World J Urol. 2024. PMID: 39297968 Free PMC article.
Treatment-related Hypertension as a Prognostic Factor for De Novo Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Real-world Evidence Study.
Salfi G, Pedrani M, Candan S, Urechie V, Merler S, Ruinelli L, Colombo A, Castelo-Branco L, Testi I, Turco F, Tortola L, Vogl U, Gabutti L, Gillessen S, Pereira Mestre R. Salfi G, et al. Among authors: vogl u. Eur Urol Open Sci. 2024 Nov 19;71:1-10. doi: 10.1016/j.euros.2024.10.023. eCollection 2025 Jan. Eur Urol Open Sci. 2024. PMID: 39641119 Free PMC article.
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives.
Turco F, Buttigliero C, Delcuratolo MD, Gillessen S, Vogl UM, Zilli T, Fossati N, Gallina A, Farinea G, Di Stefano RF, Calabrese M, Saporita I, Crespi V, Poletto S, Palesandro E, Di Maio M, Scagliotti GV, Tucci M. Turco F, et al. Among authors: vogl um. Clin Genitourin Cancer. 2024 Oct;22(5):102138. doi: 10.1016/j.clgc.2024.102138. Epub 2024 Jun 12. Clin Genitourin Cancer. 2024. PMID: 38996529 Review.
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.
Guo C, Sharp A, Gurel B, Crespo M, Figueiredo I, Jain S, Vogl U, Rekowski J, Rouhifard M, Gallagher L, Yuan W, Carreira S, Chandran K, Paschalis A, Colombo I, Stathis A, Bertan C, Seed G, Goodall J, Raynaud F, Ruddle R, Swales KE, Malia J, Bogdan D, Tiu C, Caldwell R, Aversa C, Ferreira A, Neeb A, Tunariu N, Westaby D, Carmichael J, Fenor de la Maza MD, Yap C, Matthews R, Badham H, Prout T, Turner A, Parmar M, Tovey H, Riisnaes R, Flohr P, Gil J, Waugh D, Decordova S, Schlag A, Calì B, Alimonti A, de Bono JS. Guo C, et al. Among authors: vogl u. Nature. 2023 Nov;623(7989):1053-1061. doi: 10.1038/s41586-023-06696-z. Epub 2023 Oct 16. Nature. 2023. PMID: 37844613 Free PMC article.
51 results